The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease

BackgroundInterleukin-1 beta (IL-1β) and its key regulator, the inflammasome, are suspected to play a role in the neuroinflammation observed in Alzheimer’s disease (AD); no conclusive data are nevertheless available in AD patients.ResultsmRNA for inflammasome components (NLRP1, NLRP3, PYCARD, caspase 1, 5 and 8) and downstream effectors (IL-1β, IL-18) was up-regulated in severe and MILD AD. Monocytes co-expressing NLRP3 with caspase 1 or caspase 8 were significantly increased in severe AD alone, whereas those co-expressing NLRP1 and NLRP3 with PYCARD were augmented in both severe and MILD AD. Activation of the NLRP1 and NLRP3 inflammasomes in AD was confirmed by confocal microscopy proteins co-localization and by the significantly higher amounts of the pro-inflammatory cytokines IL-1β and IL-18 being produced by monocytes. In MCI, the expression of NLRP3, but not the one of PYCARD or caspase 1 was increased, indicating that functional inflammasomes are not assembled in these individuals: this was confirmed by lack of co-localization and of proinflammatory cytokines production.ConclusionsThe activation of at least two different inflammasome complexes explains AD-associated neuroinflammation. Strategies targeting inflammasome activation could be useful in the therapy of AD.

[1]  D. Kono,et al.  Requirements for innate immune pathways in environmentally induced autoimmunity , 2013, BMC Medicine.

[2]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[3]  T. Town,et al.  CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease? , 2009, Journal of Neuroimmune Pharmacology.

[4]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[5]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[6]  D. Green,et al.  FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes , 2014, The Journal of Immunology.

[7]  S. Masters.  Specific inflammasomes in complex diseases. , 2013, Clinical immunology.

[8]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[9]  Jingfa Zhang,et al.  Silencing of the P2X(7) receptor enhances amyloid-β phagocytosis by microglia. , 2013, Biochemical and biophysical research communications.

[10]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[11]  F. Martinon,et al.  Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.

[12]  M. Lynch,et al.  Evidence That Increased Hippocampal Expression of the Cytokine Interleukin-1β Is a Common Trigger for Age- and Stress-Induced Impairments in Long-Term Potentiation , 1998, The Journal of Neuroscience.

[13]  G. Landreth,et al.  The role of microglia in amyloid clearance from the AD brain , 2010, Journal of Neural Transmission.

[14]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[15]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[16]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[17]  K. Boini,et al.  Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis , 2014, PloS one.

[18]  B. Arosio,et al.  NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease , 2012, Alzheimer disease and associated disorders.

[19]  C. Caltagirone,et al.  Increased expression of interleukin-18 receptor in blood cells of subjects with mild cognitive impairment and Alzheimer's disease. , 2013, Cytokine.

[20]  Brent D. Cameron,et al.  Inflammation, microglia, and alzheimer's disease , 2010, Neurobiology of Disease.

[21]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[22]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[23]  Steven Mills,et al.  Colocalization of fluorescent markers in confocal microscope images of plant cells , 2008, Nature Protocols.

[24]  The NLRP3 Inflammasome in Alzheimer’s Disease , 2013, Molecular Neurobiology.

[25]  Heikki Tanila,et al.  Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients , 2009, Neurobiology of Aging.

[26]  M. Heneka,et al.  Innate immunity in Alzheimer's disease , 2015, Nature Immunology.

[27]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[28]  C. Caltagirone,et al.  Interleukin-18, from neuroinflammation to Alzheimer's disease. , 2010, Current pharmaceutical design.

[29]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[30]  S. DeKosky,et al.  Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease , 2009, Molecular Psychiatry.

[31]  M. Malaguarnera,et al.  Interleukin‐18 and transforming growth factor‐beta 1 plasma levels in Alzheimer’s disease and vascular dementia , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[32]  M. Alberoni,et al.  A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[33]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[34]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[35]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  E. Manders,et al.  Chromatic shift in multicolour confocal microscopy , 1997 .

[37]  T. Kanneganti,et al.  Novel roles for caspase-8 in IL-1β and inflammasome regulation. , 2015, The American journal of pathology.

[38]  H. Müller-Hermelink,et al.  Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.

[39]  S. Masters,et al.  Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. , 2011, Trends in molecular medicine.

[40]  Jing Zhang,et al.  Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease , 2011, Molecular Neurodegeneration.

[41]  Michael T. Heneka,et al.  Innate immune activation in neurodegenerative disease , 2014, Nature Reviews Immunology.

[42]  David Miller,et al.  Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA*> , 2006, Journal of Biological Chemistry.

[43]  Vishva M. Dixit,et al.  Mechanisms and Functions of Inflammasomes , 2014, Cell.

[44]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[45]  E. Latz,et al.  Intracellular sensing of microbes and danger signals by the inflammasomes , 2011, Immunological reviews.

[46]  S. Barger,et al.  Journal of Neuroinflammation Interleukin-1 Mediates Alzheimer and Lewy Body Pathologies , 2022 .

[47]  Tuula Pirttilä,et al.  Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells , 2012, Journal of Neuroinflammation.

[48]  A. Rubartelli.  Redox control of NLRP3 inflammasome activation in health and disease , 2012, Journal of leukocyte biology.

[49]  C. Bryant,et al.  Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.

[50]  C. Tinelli,et al.  Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients , 2007, Neurobiology of Aging.

[51]  Haitao Wen,et al.  Mechanisms of NOD-like receptor-associated inflammasome activation. , 2013, Immunity.

[52]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[53]  R. Flavell,et al.  Molecular Mechanism of NLRP3 Inflammasome Activation , 2010, Journal of Clinical Immunology.

[54]  N. Delirezh,et al.  Comparison The Effects of Two Monocyte Isolation Methods, Plastic Adherence and Magnetic Activated Cell Sorting Methods, on Phagocytic Activity of Generated Dendritic Cells , 2013, Cell journal.

[55]  M. Alberoni,et al.  Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer’s disease , 2011, Brain, Behavior, and Immunity.

[56]  Takeshi Mizutani,et al.  Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity , 2014, Science.

[57]  M. Lamkanfi.  Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.

[58]  M. Pickering,et al.  Pro-inflammatory cytokines and their effects in the dentate gyrus. , 2007, Progress in brain research.

[59]  M. Schmitz,et al.  The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription , 2011, The Journal of Immunology.

[60]  D. Holtzman,et al.  Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice , 2003, The Journal of Neuroscience.

[61]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[62]  H. Anders,et al.  Uromodulin triggers IL-1β-dependent innate immunity via the NLRP3 inflammasome. , 2012, Journal of the American Society of Nephrology : JASN.

[63]  T. Suuronen,et al.  Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology , 2008, Journal of cellular and molecular medicine.

[64]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[65]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.